$CRCW
Crypto Co Stock $crcw

$crcw Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000149315223041975 Filed on November 20, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2022 Q3
Revenue	$26.29K	$124.2K	$252.7K
YoY Change	-74.67%	-50.86%	131.33%
Cost Of Revenue	$65.62K	$14.90K	$94.53K
YoY Change	-36.3%	-84.24%
Gross Profit	-$39.33K	$109.3K	$158.2K
YoY Change	-5344.0%	-30.91%	44.8%
Gross Profit Margin	-149.6%	88.0%	62.6%
Selling, General & Admin	$794.1K	$358.0K	$487.2K
YoY Change	34.91%	-26.52%	-6.19%
% of Gross Profit		327.55%	307.97%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$10.83K	$0.00	$32.71K
YoY Change	-50.18%	-100.0%
% of Gross Profit		0.0%	20.67%
Operating Expenses	$805.0K	$368.8K	$530.8K
YoY Change	31.88%	-30.51%	2.19%
Operating Profit	-$844.3K	-$259.5K	-$372.6K
YoY Change	38.5%	-30.33%	-9.16%
Interest Expense	-$150.5K	$99.31K	$47.29K
YoY Change	75.86%	110.01%	-1223.18%
% of Operating Profit
Other Income/Expense, Net	$2.600K	$0.00	$4.100K
YoY Change	-101.82%	-100.0%	-96.98%
Pretax Income	-$992.2K	-$358.8K	-$415.7K
YoY Change	18.41%	-13.68%	49.29%
Income Tax	$0.00
% Of Pretax Income
Net Earnings	-$992.2K	-$358.8K	-$415.7K
YoY Change	18.41%	-13.68%	49.29%
Net Earnings / Revenue	-3773.94%	-288.94%	-164.5%
Basic Earnings Per Share		$0.00	-$0.02
Diluted Earnings Per Share	$0.00	$0.00	-$17.80K
COMMON SHARES
Basic Shares Outstanding	309.8M shares	96.74M shares	23.15M shares
Diluted Shares Outstanding		110.8M shares	23.36M shares

Balance Sheet

Concept	2023 Q4	2023 Q3	2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$72.97K	$20.44K	$86.06K
YoY Change	-34.03%	-76.25%	-47.8%
Cash & Equivalents	$72.97K	$20.44K	$86.06K
Short-Term Investments
Other Short-Term Assets	$30.32K	$3.750K	$1.077M
YoY Change	-62.72%	-99.65%	774.51%
Inventory
Prepaid Expenses	$30.32K	$3.750K	$119.4K
Receivables
Other Receivables			$0.00
Total Short-Term Assets	$103.3K	$24.19K	$1.163M
YoY Change	-46.18%	-97.92%	303.73%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill	$740.5K	$740.5K	$740.5K
YoY Change	0.0%	0.0%
Intangibles	$530.8K
YoY Change	-7.55%
Long-Term Investments
YoY Change
Other Assets	$0.00	$0.00
YoY Change	-100.0%
Total Long-Term Assets	$1.271M	$1.282M	$1.325M
YoY Change	-6.84%	-3.27%	-0.11%
TOTAL ASSETS
Total Short-Term Assets	$103.3K	$24.19K	$1.163M
Total Long-Term Assets	$1.271M	$1.282M	$1.325M
Total Assets	$1.375M	$1.306M	$2.488M
YoY Change	-11.69%	-47.5%	54.07%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.679M	$2.632M	$2.132M
YoY Change	18.24%	23.47%	20.09%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$2.506M	$2.441M	$2.577M
YoY Change	13.34%	-5.28%	472.66%
Total Short-Term Liabilities	$5.185M	$5.073M	$4.709M
YoY Change	15.82%	7.73%	111.61%
LONG-TERM LIABILITIES
Long-Term Debt	$138.3K	$138.5K	$139.1K
YoY Change	-0.55%	-0.42%	-11.61%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$138.3K	$138.5K	$139.1K
YoY Change	-0.55%	-0.42%	-11.61%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.185M	$5.073M	$4.709M
Total Long-Term Liabilities	$138.3K	$138.5K	$139.1K
Total Liabilities	$5.324M	$5.211M	$4.848M
YoY Change	15.33%	7.5%	103.47%
SHAREHOLDERS EQUITY
Retained Earnings	-$44.45M	-$43.45M	-$38.69M
YoY Change	12.43%	12.3%
Common Stock	$40.50M	$39.55M	$36.33M
YoY Change	11.04%	8.85%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$3.949M	-$3.905M	-$2.360M
YoY Change
Total Liabilities & Shareholders Equity	$1.375M	$1.306M	$2.488M
YoY Change	-11.69%	-47.5%	54.07%

Cashflow Statement

Concept	2023 Q4	2023 Q3	2022 Q3
OPERATING ACTIVITIES
Net Income	-$992.2K	-$358.8K	-$415.7K
YoY Change	18.41%	-13.68%	49.29%
Depreciation, Depletion And Amortization	$10.83K	$0.00	$32.71K
YoY Change	-50.18%	-100.0%
Cash From Operating Activities	-$415.9K	-$173.6K	-$178.1K
YoY Change	-51.34%	-2.53%	-52.81%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$0.00	$0.00
YoY Change	-100.0%
Acquisitions
YoY Change
Other Investing Activities			$0.00
YoY Change
Cash From Investing Activities	$0.00	$0.00	$0.00
YoY Change	-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	468.5K	173.4K	245.0K
YoY Change	-549.44%	-29.2%
NET CHANGE
Cash From Operating Activities	-415.9K	-173.6K	-178.1K
Cash From Investing Activities	0.000	0.000	0.000
Cash From Financing Activities	468.5K	173.4K	245.0K
Net Change In Cash	52.54K	-180.0	66.85K
YoY Change	114.01%	-100.27%	-117.71%
FREE CASH FLOW
Cash From Operating Activities	-$415.9K	-$173.6K	-$178.1K
Capital Expenditures	$0.00	$0.00	$0.00
Free Cash Flow	-$415.9K	-$173.6K	-$178.1K
YoY Change	-422.96%	-2.53%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet		usd
CY2023Q3	us-gaap	Depreciation Depreciation		usd
	us-gaap	Depreciation Depreciation		usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Central Index Key EntityCentralIndexKey	0001688126
CY2023Q3	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Stock Redeemed Or Called During Period Value StockRedeemedOrCalledDuringPeriodValue		usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue		usd
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets		usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-55726
	dei	Entity Registrant Name EntityRegistrantName	THE CRYPTO COMPANY
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-4212105
	dei	Entity Address Address Line1 EntityAddressAddressLine1	23823 Malibu Road
	dei	Entity Address Address Line2 EntityAddressAddressLine2	# 50477
	dei	Entity Address City Or Town EntityAddressCityOrTown	Malibu
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	90265
	dei	City Area Code CityAreaCode	(424)
	dei	Local Phone Number LocalPhoneNumber	228-9955
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	309809873	shares
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	20435	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	110606	usd
CY2023Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	3750	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	81317	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	24185	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	191923	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	50000	usd
CY2023Q3	us-gaap	Goodwill Goodwill	740469	usd
CY2022Q4	us-gaap	Goodwill Goodwill	740469	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	541670	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	574169	usd
CY2023Q3	us-gaap	Assets Assets	1306324	usd
CY2022Q4	us-gaap	Assets Assets	1556561	usd
CY2023Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2632066	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2265548	usd
CY2023Q3	us-gaap	Notes Payable Current NotesPayableCurrent	2440845	usd
CY2022Q4	us-gaap	Notes Payable Current NotesPayableCurrent	2211353	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	5072911	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4476901	usd
CY2023Q3	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	125000	usd
CY2022Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	125000	usd
CY2023Q3	us-gaap	Other Long Term Notes Payable OtherLongTermNotesPayable	13510	usd
CY2022Q4	us-gaap	Other Long Term Notes Payable OtherLongTermNotesPayable	14100	usd
CY2023Q3	us-gaap	Liabilities Liabilities	5211421	usd
CY2022Q4	us-gaap	Liabilities Liabilities	4616001	usd
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2000000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2000000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	208688464	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	208688464	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	23950380	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	23950380	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	208688	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	23950	usd
CY2023Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	39340646	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	36448046	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-43454431	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-39531436	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-3905097	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-3059440	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1306324	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1556561	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	124195	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	252733	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	379107	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	515767	usd
CY2023Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	14900	usd
CY2022Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	94532	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	248136	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	266292	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	109295	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	158201	usd
	us-gaap	Gross Profit GrossProfit	130971	usd
	us-gaap	Gross Profit GrossProfit	249475	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	244183	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	305723	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	979324	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1414054	usd
CY2023Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	10833	usd
CY2022Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	10833	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	32499	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	32499	usd
CY2022Q3	us-gaap	Depreciation Depreciation	32708	usd
	us-gaap	Depreciation Depreciation	76319	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	368834	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	530752	usd
	us-gaap	Operating Expenses OperatingExpenses	1632121	usd
	us-gaap	Operating Expenses OperatingExpenses	3488869	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-259539	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-372551	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1501150	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3239394	usd
CY2022Q3	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	4100	usd
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	25775	usd
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	85865	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-31000	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	99306	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	47286	usd
	us-gaap	Interest Expense InterestExpense	2416621	usd
	us-gaap	Interest Expense InterestExpense	1671486	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-358845	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-415737	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3922996	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4825015	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-358845	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-415737	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3922996	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4825015	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.07
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.07
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.21
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.21
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	110774232	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	110774232	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	23357250	shares
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	23357250	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	57709544	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	57709544	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	22956299	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	22956299	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-3059440	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-3059440	usd
CY2023Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	5.00
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	25000.00	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	25000.00	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	388075.05	usd
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	2031499.00	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	632766	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3922996	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-3905097	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-3905097	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-1015817	usd
CY2022Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	3.28
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	26240	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	26240	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	1922247	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	43750	usd
	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	1488928	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4825015	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-2359666	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-2359666	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3922996	usd
	us-gaap	Net Income Loss NetIncomeLoss	-4825015	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	32499	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	108818	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	620298	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1965997	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2031499	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1488929	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-31000	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-77567	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	33246	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	366518	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	197932	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	21000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-763615	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1075585	usd
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	1033500	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1033500	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	195702	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	39265	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	844146	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	2132472	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	25000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	26240	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	673444	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2119447	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-90171	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	10362	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	110606	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	75699	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	20435	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	86061	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2281429	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.26
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y3M
CY2023Q3	us-gaap	Cash Cash	20435	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3922996	usd
	CRCW	Working Capital WorkingCapital	-5048726	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-43454431	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84A_eus-gaap--UseOfEstimates_zBE9PUN9Lfh2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span style="text-decoration: underline"><span id="xdx_869_zRlWhXLxpgal">Use of Estimates</span></span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of these condensed consolidated financial statements in conformity with GAAP requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues, and expenses and the related disclosure of contingent assets and liabilities. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. The Company’s significant estimates and assumptions include but are not limited to the valuation allowances of deferred taxes, and share-based compensation expenses. Actual results may differ from these estimates. In addition, any change in these estimates or their related assumptions could have an adverse effect on the Company’s operating results.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q3	us-gaap	Goodwill Gross GoodwillGross	1349457	usd
CY2023Q3	us-gaap	Goodwill Goodwill	740469	usd
CY2023Q3	us-gaap	Intangible Assets Net Including Goodwill IntangibleAssetsNetIncludingGoodwill	650000	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	54166	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	32499	usd
CY2023Q3	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	125000	usd
CY2022Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	125000	usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2281429	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.26
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y6M
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2281429	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.26
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y6M
CY2023Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	0	usd
	us-gaap	Payments For Rent PaymentsForRent	0	usd
	us-gaap	Payments For Rent PaymentsForRent	0	usd
CY2023Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0001493152-23-041975-index-headers.html	Edgar Link	pending
0001493152-23-041975-index.html	Edgar Link	pending
0001493152-23-041975.txt	Edgar Link	pending
0001493152-23-041975-xbrl.zip	Edgar Link	pending
crcw-20230930.xsd	Edgar Link	pending
ex10-4.htm	Edgar Link	pending
ex10-4_001.jpg	Edgar Link	pending
ex10-4_002.jpg	Edgar Link	pending
ex10-4_003.jpg	Edgar Link	pending
ex10-4_004.jpg	Edgar Link	pending
ex10-4_005.jpg	Edgar Link	pending
ex10-4_006.jpg	Edgar Link	pending
ex10-4_007.jpg	Edgar Link	pending
ex10-4_008.jpg	Edgar Link	pending
ex10-4_009.jpg	Edgar Link	pending
ex10-4_010.jpg	Edgar Link	pending
crcw-20230930_cal.xml	Edgar Link	unprocessable
crcw-20230930_def.xml	Edgar Link	unprocessable
crcw-20230930_pre.xml	Edgar Link	unprocessable
crcw-20230930_lab.xml	Edgar Link	unprocessable
ex10-4_011.jpg	Edgar Link	pending
ex10-4_012.jpg	Edgar Link	pending
ex10-4_013.jpg	Edgar Link	pending
ex10-4_014.jpg	Edgar Link	pending
ex10-4_015.jpg	Edgar Link	pending
ex10-4_016.jpg	Edgar Link	pending
ex10-4_017.jpg	Edgar Link	pending
ex10-4_018.jpg	Edgar Link	pending
ex10-4_019.jpg	Edgar Link	pending
ex10-4_020.jpg	Edgar Link	pending
ex10-4_021.jpg	Edgar Link	pending
ex10-4_022.jpg	Edgar Link	pending
ex10-4_023.jpg	Edgar Link	pending
ex10-4_024.jpg	Edgar Link	pending
ex10-5.htm	Edgar Link	pending
ex10-5_001.jpg	Edgar Link	pending
ex10-5_002.jpg	Edgar Link	pending
ex10-5_003.jpg	Edgar Link	pending
ex10-5_004.jpg	Edgar Link	pending
ex10-5_005.jpg	Edgar Link	pending
ex10-5_006.jpg	Edgar Link	pending
ex10-5_007.jpg	Edgar Link	pending
ex10-5_008.jpg	Edgar Link	pending
ex10-5_009.jpg	Edgar Link	pending
ex10-5_010.jpg	Edgar Link	pending
ex10-5_011.jpg	Edgar Link	pending
ex10-5_012.jpg	Edgar Link	pending
ex10-5_013.jpg	Edgar Link	pending
ex10-5_014.jpg	Edgar Link	pending
ex10-5_015.jpg	Edgar Link	pending
ex10-5_016.jpg	Edgar Link	pending
ex10-5_017.jpg	Edgar Link	pending
ex10-5_018.jpg	Edgar Link	pending
ex10-5_019.jpg	Edgar Link	pending
ex10-5_020.jpg	Edgar Link	pending
ex10-5_021.jpg	Edgar Link	pending
ex10-5_022.jpg	Edgar Link	pending
ex10-5_023.jpg	Edgar Link	pending
ex10-5_024.jpg	Edgar Link	pending
ex10-5_025.jpg	Edgar Link	pending
ex10-6.htm	Edgar Link	pending
ex10-6_001.jpg	Edgar Link	pending
ex10-6_002.jpg	Edgar Link	pending
ex10-6_003.jpg	Edgar Link	pending
ex10-6_004.jpg	Edgar Link	pending
ex10-6_005.jpg	Edgar Link	pending
ex10-6_006.jpg	Edgar Link	pending
ex10-6_007.jpg	Edgar Link	pending
ex10-6_008.jpg	Edgar Link	pending
ex10-6_009.jpg	Edgar Link	pending
ex10-6_010.jpg	Edgar Link	pending
ex10-6_011.jpg	Edgar Link	pending
ex10-6_012.jpg	Edgar Link	pending
ex10-6_013.jpg	Edgar Link	pending
ex10-6_014.jpg	Edgar Link	pending
ex10-6_015.jpg	Edgar Link	pending
ex10-6_016.jpg	Edgar Link	pending
ex10-6_017.jpg	Edgar Link	pending
ex10-6_018.jpg	Edgar Link	pending
ex10-6_019.jpg	Edgar Link	pending
ex10-7.htm	Edgar Link	pending
ex10-7_001.jpg	Edgar Link	pending
ex10-7_002.jpg	Edgar Link	pending
ex10-7_003.jpg	Edgar Link	pending
ex10-7_004.jpg	Edgar Link	pending
ex10-7_005.jpg	Edgar Link	pending
ex10-7_006.jpg	Edgar Link	pending
ex10-7_007.jpg	Edgar Link	pending
ex10-7_008.jpg	Edgar Link	pending
ex10-7_009.jpg	Edgar Link	pending
ex10-7_010.jpg	Edgar Link	pending
ex10-7_011.jpg	Edgar Link	pending
ex10-7_012.jpg	Edgar Link	pending
ex10-7_013.jpg	Edgar Link	pending
ex10-7_014.jpg	Edgar Link	pending
ex10-7_015.jpg	Edgar Link	pending
ex10-7_016.jpg	Edgar Link	pending
ex10-7_017.jpg	Edgar Link	pending
ex10-7_018.jpg	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
form10-q_htm.xml	Edgar Link	completed
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CRCW
Crypto Co Stock $crcw

2023 Q4 Form 10-Q Financial Statement

#000149315223041975 Filed on November 20, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CRCW Crypto Co Stock $crcw

2023 Q4 Form 10-Q Financial Statement

#000149315223041975 Filed on November 20, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CRCW
Crypto Co Stock $crcw